Cargando…

RNA sequencing-based identification of potential targets in acute myeloid leukemia: A case report

Acute myeloid leukemia (AML) refers to heterogenous types of blood cancer which possess a complicated genomic landscape, and multiple novel mutational alterations are frequently being reported. Herein, a case report of a 37-year old AML patient is presented, who was diagnosed following laboratory in...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Masry, Omar S., Al-Amri, Ali M., Alqatari, Ahlam, Alsamman, Khaldoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469581/ https://www.ncbi.nlm.nih.gov/pubmed/32934815 http://dx.doi.org/10.3892/br.2020.1349

Ejemplares similares

ADAMTS14, ARHGAP22, and EPDR1 as potential novel targets in acute myeloid leukaemia
por: El-Masry, Omar S., et al.
Publicado: (2022)

RNA sequencing identified novel target genes for Adansonia digitata in breast and colon cancer cells
por: El-Masry, Omar S., et al.
Publicado: (2021)

Whole-transcriptome bioinformatics revealed HTRA3, KRT8, KRT17, and RHEX as novel targets in acute myeloid leukaemia
por: El-Masry, Omar S., et al.
Publicado: (2022)

Interferon regulatory factor 1 inactivation in human cancer
por: Alsamman, Khaldoon, et al.
Publicado: (2018)

Oral Intragastric DMBA Administration Induces Acute Lymphocytic Leukemia and Other Tumors in Male Wistar Rats
por: El-Masry, Omar S, et al.
Publicado: (2022)

Novel IRF-1 Mutations in a Small Cohort of Leukaemia Patients From Saudi Arabia
por: Alsamman, Khaldoon, et al.
Publicado: (2017)

Sudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemia
por: Buzaid, Ahmed N., et al.
Publicado: (2017)

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
por: Dillon, Laura W., et al.
Publicado: (2019)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Targeting mitochondrial RNA polymerase in acute myeloid leukemia
por: Bralha, Fernando N., et al.
Publicado: (2015)

Potential targeting of FLT3 acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2020)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

Acute Myeloid Leukemia: Is That All There Is?
por: Saif, Aneeqa, et al.
Publicado: (2018)

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia
por: Glass, Carolyn, et al.
Publicado: (2013)

Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing
por: Arindrarto, Wibowo, et al.
Publicado: (2020)

The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia
por: Madaci, Lamia, et al.
Publicado: (2023)

Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival
por: Zhang, Chunmei, et al.
Publicado: (2017)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
por: El Fakih, Riad, et al.
Publicado: (2018)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

The Potential Role of 3D In Vitro Acute Myeloid Leukemia Culture Models in Understanding Drug Resistance in Leukemia Stem Cells
por: Al-Kaabneh, Basil, et al.
Publicado: (2022)

ERIC-PCR Genotyping of Acinetobacter baumannii Isolated from Different Clinical Specimens
por: Aljindan, Reem, et al.
Publicado: (2018)

Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
por: Roma, Alessia, et al.
Publicado: (2023)

Identification of long non‐coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia
por: Jiang, Zhiyong, et al.
Publicado: (2019)

Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
por: Zhi, Feng, et al.
Publicado: (2013)

Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia
por: Pan, Pan, et al.
Publicado: (2020)

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia
por: Cumbo, Cosimo, et al.
Publicado: (2019)

Next Generation Sequencing of Acute Myeloid Leukemia: Influencing Prognosis
por: Ilyas, Asad Muhammad, et al.
Publicado: (2015)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
por: Minuesa, Gerard, et al.
Publicado: (2019)

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
por: Lo, Tsun-Ho, et al.
Publicado: (2019)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
por: Zhou, Yujia, et al.
Publicado: (2020)

Breast cancer resistance protein (BCRP) gene expression in a cohort of adult Egyptian patients with acute myeloid leukemia
por: El-Masry, Manal W, et al.
Publicado: (2018)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia
por: Huang, Xiao, et al.
Publicado: (2019)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v4744uhjduuseuuuqu6dvok15h